Updates are available Correction dated 2022-12-12
Click to view Correction: https://doi.org/10.1186/s40814-022-01219-5
-
Authors
Kearns, Noreen http://orcid.org/0000-0003-3161-4569
Raigal-Aran, Laia
O’Connell, Kate
Davis, Andrea
Bermingham, Katie
O’Reilly, Seamus
Collins, Dearbhaile C.
Corrigan, Mark
Coulter, John
Cleary, Vicki
Cushen, Samantha
Flavin, Aileen
Byrne, Fiona
O’Grady, Aisling
O’Neill, Deirdre
Murphy, Aileen
Dahly, Darren
Palmer, Brendan
Connolly, Roisin M.
Hegarty, Josephine
-
Funding
Funding for this research was provided by:
Irish Cancer Society (WHI19CON)
Breakthrough Cancer Research (BCR-2019-09-ICS-UCC)
- License Information
-
More Information
Article History
Received: 3 May 2022
Accepted: 12 October 2022
First Online: 10 November 2022
Change Date: 12 December 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s40814-022-01219-5
Declarations
:
: Ethical approval was granted by the Clinical Research Ethics Committee of Cork Teaching Hospitals in December 2020 (ECM 4 (y) 20/10/2020). All participants will be required to provide written informed consent (hard copy/electronically).
: Not applicable.
: RMC received a global education grant from Pfizer, and research funding from Merck Sharp and Dohme (MSD) Ireland, Pfizer, Daichii Sankyo, and Astra Zeneca to her institution. JH received a research grant from Pfizer. The other authors declare that they have no competing interests.
